Insmed Inc
NASDAQ:INSM
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
22
79.01
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Insmed Inc
Wall Street
Price Targets
INSM Price Targets Summary
Insmed Inc
According to Wall Street analysts, the average 1-year price target for
INSM
is 91.19 USD
with a low forecast of 75.75 USD and a high forecast of 110.25 USD.
INSM Last Price Targets
Insmed Inc
The latest public price target was made on Aug 15, 2024 by
Graig Suvannavejh
from
Mizuho Securities
,
who expects
INSM
stock to
rise by 31%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Graig Suvannavejh
Mizuho Securities
|
92
USD
Upside 31% |
4 months ago
Aug 15, 2024
|
Insmed (INSM) PT Raised to $92 at Mizuho, 'continue to favor it as our top longer-term idea'
StreetInsider
|
Tiago Fauth
Wells Fargo
|
85
USD
Upside 21% |
4 months ago
Aug 9, 2024
|
Insmed price target raised to $85 from $77 at Wells Fargo
TheFly
|
Vamil Divan
Guggenheim
|
95
USD
Upside 35% |
5 months ago
Jul 9, 2024
|
Insmed price target raised to $95 from $70 at Guggenheim
TheFly
|
Nicole Germino
Truist Financial
|
88
USD
Upside 25% |
5 months ago
Jul 1, 2024
|
Insmed (INSM) PT Raised to $88 at Truist Securities
StreetInsider
|
Leon Wang
Barclays
|
90
USD
Upside 28% |
5 months ago
Jun 25, 2024
|
Insmed (INSM) PT Raised to $90 at Barclays
StreetInsider
|
Liisa Bayko
Evercore ISI
|
75
USD
Upside 6% |
6 months ago
Jun 21, 2024
|
Insmed (INSM) PT Raised to $75 at Evercore ISI
StreetInsider
|
|
Graig Suvannavejh
Mizuho Securities
|
82
USD
Upside 16% |
6 months ago
Jun 7, 2024
|
Insmed (INSM) PT Raised to $82 at Mizuho
StreetInsider
|
Stephen Willey
Stifel Nicolaus
|
74
USD
Upside 5% |
6 months ago
Jun 5, 2024
|
Insmed price target raised to $74 from $67 at Stifel
TheFly
|
|
Nicole Germino
Truist Financial
|
68
USD
Downside 3% |
6 months ago
May 29, 2024
|
Insmed (INSM) PT Raised to $68 at Truist Securities
StreetInsider
|
|
Andrew Fein
H.C. Wainwright
|
70
USD
Downside 1% |
6 months ago
May 29, 2024
|
Insmed (INSM) PT Raised to $70 at H.C. Wainwright
StreetInsider
|
Andy Chen
Wolfe Research
|
54
USD
Downside 23% |
6 months ago
May 29, 2024
|
Insmed (INSM) PT Raised to $54 at Wolfe Research
StreetInsider
|
|
Tiago Fauth
Wells Fargo
|
77
USD
Upside 9% |
6 months ago
May 29, 2024
|
Insmed (INSM) PT Raised to $77 at Wells Fargo
StreetInsider
|
Trung Huynh
UBS
|
58
USD
Downside 18% |
6 months ago
May 29, 2024
|
Insmed (INSM) PT Raised to $58 at UBS
StreetInsider
|
Andrea Tan
Goldman Sachs
|
74
USD
Upside 5% |
6 months ago
May 28, 2024
|
Goldman Sachs Reiterates Buy Rating on Insmed (INSM)
StreetInsider
|
Jeffrey Hung
Morgan Stanley
|
60
USD
Downside 15% |
6 months ago
May 28, 2024
|
Insmed (INSM) PT Raised to $60 at Morgan Stanley
StreetInsider
|
|
Liisa Bayko
Evercore ISI
|
42
USD
Downside 40% |
6 months ago
May 28, 2024
|
Evercore ISI Reiterates Outperform Rating on Insmed (INSM)
StreetInsider
|
|
Graig Suvannavejh
Mizuho Securities
|
36
USD
Downside 49% |
7 months ago
May 13, 2024
|
Insmed (INSM) PT Raised to $36 at Mizuho
StreetInsider
|
|
Jeffrey Hung
Morgan Stanley
|
43
USD
Downside 39% |
7 months ago
May 9, 2024
|
Insmed (INSM) PT Raised to $43 at Morgan Stanley
StreetInsider
|
|
Nicole Germino
Truist Financial
|
48
USD
Downside 32% |
8 months ago
Apr 23, 2024
|
Truist Securities Starts Insmed (INSM) at Buy
StreetInsider
|
|
Tiago Fauth
Wells Fargo
|
55
USD
Downside 22% |
8 months ago
Apr 1, 2024
|
Wells Fargo Adds Insmed (INSM) to Q2 '24 Tactical Idea List
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is INSM's stock price target?
Price Target
91.19
USD
According to Wall Street analysts, the average 1-year price target for
INSM
is 91.19 USD
with a low forecast of 75.75 USD and a high forecast of 110.25 USD.
What is Insmed Inc's Revenue forecast?
Projected CAGR
63%
The
compound annual growth rate
of Insmed Inc's revenue for the next 4 years is
63%.
You don't have any saved screeners yet
